Cargando…

Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives

Notwithstanding regulatory approval of lenvatinib and sorafenib to treat radioiodine-refractory differentiated thyroid carcinoma (RAI-R DTC), important questions and controversies persist regarding this use of these tyrosine kinase inhibitors (TKIs). RAI-R DTC experts from German tertiary referral c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verburg, Frederik A., Amthauer, Holger, Binse, Ina, Brink, Ingo, Buck, Andreas, Darr, Andreas, Dierks, Christine, Koch, Christine, König, Ute, Kreissl, Michael C., Luster, Markus, Reuter, Christoph, Scheidhauer, Klemens, Willenberg, Holger Sven, Zielke, Andreas, Schott, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932822/ https://www.ncbi.nlm.nih.gov/pubmed/33652491 http://dx.doi.org/10.1055/a-1380-4154

Ejemplares similares

Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country
por: Eilsberger, Friederike, et al.
Publicado: (2020)

Chewing-gum stimulation did not reduce the absorbed dose to salivary glands during radioiodine treatment of thyroid cancer as inferred from pre-therapy (124)I PET/CT imaging
por: Jentzen, Walter, et al.
Publicado: (2014)

Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer
por: Al-Ibraheem, Akram, et al.
Publicado: (2009)

Enhancing Radioiodine Incorporation into Radioiodine-Refractory Thyroid Cancer with MAPK Inhibition (ERRITI): A Single-Center Prospective Two-Arm Study
por: Weber, Manuel, et al.
Publicado: (2022)

Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat
por: van Velsen, Evert F S, et al.
Publicado: (2023)

Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023)

Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysis
por: Vardarli, I., et al.
Publicado: (2020)

Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German Population
por: Eilsberger, Friederike, et al.
Publicado: (2023)

The EANM guideline on radioiodine therapy of benign thyroid disease
por: Campennì, Alfredo, et al.
Publicado: (2023)

Many Channels Lead to Aldosterone()
por: Willenberg, Holger S.
Publicado: (2016)

Optimization of SPECT/CT imaging protocols for quantitative and qualitative (99m)Tc SPECT
por: Kupitz, Dennis, et al.
Publicado: (2021)

(68)Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with(18)F-FDG, calcium burden and risk factors
por: Li, Xiang, et al.
Publicado: (2012)

Successful combination of selpercatinib and radioiodine after pretherapeutic dose estimation in RET-altered thyroid carcinoma
por: Werner, Rudolf A., et al.
Publicado: (2022)

Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?
por: Wetz, Christoph, et al.
Publicado: (2020)

Hypoparathyroidism – management, information needs, and impact on daily living from the patients’ perspective: results from a population-based survey
por: Büttner, Matthias, et al.
Publicado: (2023)

Ultrasound Assessment of Autonomous Thyroid Nodules before and after Radioiodine Therapy Using Thyroid Imaging Reporting and Data System (TIRADS)
por: Schenke, Simone Agnes, et al.
Publicado: (2020)

Aldosterone-Mediated Sodium Retention Is Reflected by the Serum Sodium to Urinary Sodium to (Serum Potassium)(2) to Urinary Potassium (SUSPPUP) Index
por: Kanaan, Evelien, et al.
Publicado: (2020)

PET-CT in the diagnosis of cardiac and pulmonary sarcoidosis
por: Brugger, Marcus, et al.
Publicado: (2022)

Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project
por: Taprogge, Jan, et al.
Publicado: (2023)

Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningioma
por: Kreissl, Michael C, et al.
Publicado: (2012)

Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
por: Hoeflich, Andreas, et al.
Publicado: (2020)

Bilateral mydriasis as first manifestation of Hodgkin’s lymphoma: a case report
por: Baki, Enayatullah, et al.
Publicado: (2022)

FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
por: Adam, Pia, et al.
Publicado: (2021)

Controversies about the Secondary Prevention of Spontaneous Preterm Birth
por: Kyvernitakis, Ioannis, et al.
Publicado: (2018)

Papillary renal cell carcinoma: current and controversial issues
por: Angori, Silvia, et al.
Publicado: (2022)

Radioiodinated indomethacin amide for molecular imaging of cyclooxygenase-2 expressing tumors
por: Morgenroth, Agnieszka, et al.
Publicado: (2017)

Introducing the HemaSphere Controversies Series
por: Eichenauer, Dennis A., et al.
Publicado: (2019)

Controversies in the Management of Endometrial Cancer
por: Hernandez, Enrique, et al.
Publicado: (2010)

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
por: Pacini, Furio, et al.
Publicado: (2021)

Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit
por: Wirth, Lori J, et al.
Publicado: (2022)

Is the aptitude of manual skills enough for assessing the training effect of students using a laparoscopy simulator?
por: Hassan, Iyad, et al.
Publicado: (2005)

False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
por: Barbaro, Daniele, et al.
Publicado: (2023)

Controversies in the Treatment of Classical Hodgkin Lymphoma
por: Eichenauer, Dennis A., et al.
Publicado: (2018)

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice
por: Capdevila, Jaume, et al.
Publicado: (2023)

Iterative CT reconstruction in abdominal low-dose CT used for hybrid SPECT-CT applications: effect on image quality, image noise, detectability, and reader’s confidence
por: Grosser, Oliver S, et al.
Publicado: (2019)

The association of intra-therapeutic heterogeneity of somatostatin receptor expression with morphological treatment response in patients undergoing PRRT with [(177)Lu]-DOTATATE
por: Wetz, Christoph, et al.
Publicado: (2019)

Controversies in second language writing : dilemmas and decisions in research and instruction
por: Casanave, Christine Pearson, 1944-
Publicado: (2007)

A pretest–posttest pilot study for the development and preliminary validation of a tool for the clinical assessment of radioiodine induced sialadenitis
por: Christou, Andri, et al.
Publicado: (2021)

Radioiodine Biogeochemistry and Prevalence in Groundwater
por: Kaplan, D. I., et al.
Publicado: (2014)

Responsibilities and Protection in the Use of Radioiodine
por: O'Doherty, MJ, et al.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_2bte85bdod4nvjqlq7m3kp8cpl